Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nitrofurantoin - oral suspension - 5mg/1ml

Australia - engleză - Department of Health (Therapeutic Goods Administration)

boc limited - oxygen, quantity: 0.5 l/l; nitrous oxide, quantity: 0.5 l/l - gas, medicinal - excipient ingredients: - indications as at 1 november 2001: "nitrous oxide with oxygen (entonox) is indicated in adults and children for analgesia." this approval is based on the evaluation of the information and data provided with the original letter of application and with any subsequent correspondence and submissions relating to the application.

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

amdipharm limited - nitrofurantoin - capsule, hard - 100 milligram(s) - nitrofuran derivatives; nitrofurantoin

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

amdipharm limited - nitrofurantoin - capsule, hard - 50 milligram(s) - nitrofuran derivatives; nitrofurantoin

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

cardinal health - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion. not for use as a systemic alkalizer. none known.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

hospira, inc. - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20, sodium cation - unii:lyr4m0nh37) - neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion. not for use as a systemic alkalizer. none known.

Malta - engleză - Medicines Authority

amdipharm limited temple chambers, 3 burlington road, dublin 4, ireland - nitrofurantoin - hard capsule - nitrofurantoin 50 mg - antibacterials for systemic use

Malta - engleză - Medicines Authority

amdipharm limited temple chambers, 3 burlington road, dublin 4, ireland - nitrofurantoin - hard capsule - nitrofurantoin 100 mg - antibacterials for systemic use

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rising pharma holdings, inc. - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli , enterococci , staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. consequently, many patients who are treated with nitrofurantoin are predisposed to persistence or reappearance of bacteriuria. urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. if persistence or reappearance of bacteriuria occurs after treatment with nitrofurantoin , other therapeutic agents with broader tissue distribution should be selected. in considering the use of nitrofurantoin , lower eradication rates should be balanced against the increased potential for systemic toxicity and fo

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

lifestar pharma llc - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin capsules (macrocrystals) are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli , enterococci, staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules (macrocrystals) and other antibacterial drugs, nitrofurantoin capsules (macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other the